0.1900
-0.0010
(-0.52%)
At close: 8:11:34 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
56,043.0000
56,043.0000
48,477.0000
36,864.0000
20,602.0000
Cost of Revenue
24,170.0000
--
--
963.0000
727.0000
Gross Profit
31,873.0000
--
--
35,901.0000
19,875.0000
Operating Expense
45,722.0000
45,722.0000
42,335.0000
36,568.0000
28,485.0000
Operating Income
10,321.0000
10,321.0000
6,142.0000
296.0000
-8,610.0000
Net Non Operating Interest Income Expense
1,005.0000
1,005.0000
4.0000
-215.0000
-374.0000
Pretax Income
11,147.0000
11,147.0000
-365.0000
277.0000
-10,980.0000
Tax Provision
-4,968.0000
-4,968.0000
411.0000
351.0000
-189.0000
Net Income Common Stockholders
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Diluted NI Available to Com Stockholders
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Basic EPS
0.02
--
-0.00
-0.00
-0.02
Diluted EPS
0.02
--
-0.00
-0.00
-0.02
Basic Average Shares
677,444.1330
--
670,943.9180
670,187.3130
599,920.2070
Diluted Average Shares
685,847.3150
--
688,710.3740
670,187.3130
599,920.2070
Total Operating Income as Reported
10,102.0000
10,102.0000
6,023.0000
590.0000
-10,259.0000
Rent Expense Supplemental
--
--
--
1,399.0000
1,331.0000
Total Expenses
45,722.0000
45,722.0000
42,335.0000
36,568.0000
29,212.0000
Net Income from Continuing & Discontinued Operation
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Normalized Income
16,292.3900
16,292.3900
4,955.5600
-290.2700
-8,934.5156
Interest Income
1,181.0000
1,181.0000
136.0000
12.0000
--
Interest Expense
155.0000
155.0000
133.0000
227.0000
374.0000
Net Interest Income
1,005.0000
1,005.0000
4.0000
-215.0000
-374.0000
EBIT
11,302.0000
11,302.0000
-232.0000
504.0000
-10,606.0000
EBITDA
14,018.0000
14,018.0000
2,698.0000
3,069.0000
-8,554.0000
Reconciled Cost of Revenue
24,170.0000
--
--
963.0000
727.0000
Reconciled Depreciation
2,716.0000
2,716.0000
2,930.0000
2,565.0000
2,052.0000
Net Income from Continuing Operation Net Minority Interest
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Total Unusual Items Excluding Goodwill
-219.0000
-219.0000
-7,076.0000
267.0000
-1,889.0000
Total Unusual Items
-219.0000
-219.0000
-7,076.0000
267.0000
-1,889.0000
Normalized EBITDA
14,237.0000
14,237.0000
9,774.0000
2,802.0000
-6,665.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0000
Tax Effect of Unusual Items
-41.6100
-41.6100
-1,344.4400
50.7300
-32.5156
12/31/2020 - 6/24/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1U5.F Wave Life Sciences Ltd.
10.20
+4.62%
6XY.F HBM Holdings Limited
0.4700
-6.93%
6K9.F Context Therapeutics Inc.
0.7300
+2.10%
PHPN.F Galectin Therapeutics Inc.
1.2000
-2.44%
EU6.F PDS Biotechnology Corporation
1.2320
-8.94%
RFM.F Sensorion SA
0.5800
-0.68%
AYJ.DE Valneva SE
3.6960
-6.67%
ALTME.PA TME Pharma N.V.
0.0753
+1.07%
BX2.F BioXcel Therapeutics, Inc.
0.0000
-30.22%
J90.F NurExone Biologic Inc.
0.4440
+11.56%